StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30208% above fair value
$238.10+5.02 (+2.15%)

Close on Nov 19, 2026Market cap $14.09BP/E –Yield –

Glaukos free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Glaukos's free cash flow for the twelve months ending Sep 30, 2026 was $36.02M. For fiscal 2025 it was -$22.46M. The highest annual figure on record is $19.78M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.46M–
FY2024Dec 31, 2024-$67.62M–
FY2023Dec 31, 2023-$78.01M–
FY2022Dec 31, 2022-$63.35M–
FY2021Dec 31, 2021-$23.08M–
FY2020Dec 31, 2020-$29.92M–
FY2019Dec 31, 2019-$5.09M-159.6%
FY2018Dec 31, 2018$8.55M-56.8%
FY2017Dec 31, 2017$19.78M+228.0%
FY2016Dec 31, 2016$6.03M–
FY2015Dec 31, 2015-$3.07M–
FY2014Dec 31, 2014-$7.98M–
FY2013Dec 31, 2013-$14.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$36.49M–
Q2 FY2026Jun 30, 2026$12.09M+108.4%
Q1 FY2026Mar 31, 2026-$16.49M–
Q4 FY2025Dec 31, 2025$3.93M–
Q3 FY2025Sep 30, 2025-$11.73M–
Q2 FY2025Jun 30, 2025$5.80M–
Q1 FY2025Mar 31, 2025-$20.46M–
Q4 FY2024Dec 31, 2024-$1.23M–
Q3 FY2024Sep 30, 2024-$11.04M–
Q2 FY2024Jun 30, 2024-$20.52M–
Q1 FY2024Mar 31, 2024-$34.84M–
Q4 FY2023Dec 31, 2023-$14.88M–
Q3 FY2023Sep 30, 2023-$11.53M–
Q2 FY2023Jun 30, 2023-$13.93M–
Q1 FY2023Mar 31, 2023-$37.67M-1288.4%
Q4 FY2022Dec 31, 2022-$12.36M–
Q3 FY2022Sep 30, 2022-$32.55M-513.4%
Q2 FY2022Jun 30, 2022-$21.61M–
Q1 FY2022Mar 31, 2022$3.17M–
Q4 FY2021Dec 31, 2021-$13.98M-265.2%
Q3 FY2021Sep 30, 2021$7.87M–
Q2 FY2021Jun 30, 2021-$3.97M–
Q1 FY2021Mar 31, 2021-$13.00M–
Q4 FY2020Dec 31, 2020$8.46M–
Q3 FY2020Sep 30, 2020-$10.85M–
Q2 FY2020Jun 30, 2020-$13.65M-388.6%
Q1 FY2020Mar 31, 2020-$13.88M–
Q4 FY2019Dec 31, 2019-$5.39M-156.4%
Q3 FY2019Sep 30, 2019-$4.00M-209.9%
Q2 FY2019Jun 30, 2019$4.73M+54.3%
Q1 FY2019Mar 31, 2019-$443.00K–
Q4 FY2018Dec 31, 2018$9.55M-10.0%
Q3 FY2018Sep 30, 2018$3.64M-21.1%
Q2 FY2018Jun 30, 2018$3.07M+2.2%
Q1 FY2018Mar 31, 2018-$7.70M-591.6%
Q4 FY2017Dec 31, 2017$10.60M+757.9%
Q3 FY2017Sep 30, 2017$4.61M–
Q2 FY2017Jun 30, 2017$3.00M–
Q1 FY2017Mar 31, 2017$1.57M–
Q4 FY2016Dec 31, 2016$1.24M–

More Glaukos figures

See a number that looks wrong?